Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/cisplatin with or without folic acid and vitamin B12 in advanced esophagogastric cancer
NL-OMON23015Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2004
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of gemcitabine, cisplatin, folic acid and cyanocobalamin in Esophagogastric Cancer (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Response rate. Started Mar 2004; status: active, not recruiting.
02
Drugs
gemcitabinecisplatinfolic acidcyanocobalamin
03
Conditions
Esophagogastric Cancer
Beyond the preview
Go deeper on NL-OMON23015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23015.